Prostate Cancer Trial, Recruiting (NCT06636526)

Prostate Cancer Trial, Recruiting NCT06636526 Sponsor: Institute of Cancer Research, United Kingdom Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06636526 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who were born male (and therefore have a prostate).
People aged between 40 and 55 years old.
People of Black African, Black African-Caribbean, White European, South Asian, or East Asian ancestry — defined as having all four grandparents from the same ancestry background.
People who do not have any psychological, family, social, or location-related circumstances that could make it difficult to follow the study's requirements and attend scheduled visits.

Who may not be able to join:

People who have previously been diagnosed with prostate cancer.
People of mixed ancestry.
People who have previously been diagnosed with another cancer that has left them with a life expectancy of less than five years.
People who have had a negative prostate biopsy within the year before joining the trial.
People who have a significant psychological condition that could be made worse by taking part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rosalind A Eeles, FRCP; FRCR, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust

Phone: +44 208 722 4483

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06636526

Sponsor: Institute of Cancer Research, United Kingdom

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: +44 208 722 4483

More information: https://clinicaltrials.gov/study/NCT06636526

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who were born male (and therefore have a prostate).
People aged between 40 and 55 years old.
People of Black African, Black African-Caribbean, White European, South Asian, or East Asian ancestry — defined as having all four grandparents from the same ancestry background.
People who do not have any psychological, family, social, or location-related circumstances that could make it difficult to follow the study's requirements and attend scheduled visits.

Who may not be able to join:

People who have previously been diagnosed with prostate cancer.
People of mixed ancestry.
People who have previously been diagnosed with another cancer that has left them with a life expectancy of less than five years.
People who have had a negative prostate biopsy within the year before joining the trial.
People who have a significant psychological condition that could be made worse by taking part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institute of Cancer Research, United Kingdom

Registry

ClinicalTrials.gov

Start date

2 June 2025

Est. completion

1 December 2028

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

The number of participants stratified by each ethnic background recruited and risk stratified using the i4i PRODICT® test.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov